| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatitis | 24 | 2024 | 137 | 4.450 |
Why?
|
| Endoscopy, Gastrointestinal | 27 | 2023 | 241 | 4.160 |
Why?
|
| Pancreatitis, Chronic | 25 | 2024 | 68 | 3.790 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 18 | 2023 | 80 | 3.220 |
Why?
|
| Gastroenterology | 13 | 2024 | 204 | 2.140 |
Why?
|
| Colonoscopy | 9 | 2023 | 239 | 1.850 |
Why?
|
| Endoscopy | 8 | 2022 | 282 | 1.790 |
Why?
|
| Pancreas | 8 | 2022 | 222 | 1.630 |
Why?
|
| Choledocholithiasis | 4 | 2021 | 14 | 1.630 |
Why?
|
| Pancreatic Diseases | 5 | 2017 | 38 | 1.540 |
Why?
|
| Pediatrics | 15 | 2024 | 1161 | 1.450 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2022 | 232 | 1.430 |
Why?
|
| Cholestasis | 5 | 2025 | 155 | 1.400 |
Why?
|
| Esophageal Stenosis | 2 | 2020 | 45 | 1.310 |
Why?
|
| Child | 80 | 2025 | 24766 | 1.300 |
Why?
|
| Cystic Fibrosis | 3 | 2020 | 258 | 1.170 |
Why?
|
| Foreign Bodies | 4 | 2021 | 106 | 1.030 |
Why?
|
| Recurrence | 19 | 2024 | 1400 | 1.000 |
Why?
|
| Acute Disease | 23 | 2024 | 1103 | 0.940 |
Why?
|
| Intussusception | 5 | 2014 | 48 | 0.940 |
Why?
|
| Humans | 124 | 2025 | 126330 | 0.890 |
Why?
|
| Celiac Disease | 4 | 2024 | 67 | 0.840 |
Why?
|
| Occupational Injuries | 1 | 2022 | 9 | 0.790 |
Why?
|
| Endoscopy, Digestive System | 5 | 2023 | 152 | 0.780 |
Why?
|
| Quality Improvement | 8 | 2022 | 653 | 0.770 |
Why?
|
| Occupational Diseases | 1 | 2022 | 74 | 0.750 |
Why?
|
| Musculoskeletal Diseases | 1 | 2022 | 57 | 0.750 |
Why?
|
| Endosonography | 6 | 2023 | 80 | 0.750 |
Why?
|
| Clinical Competence | 6 | 2024 | 1008 | 0.720 |
Why?
|
| Amyloidosis | 1 | 2022 | 68 | 0.710 |
Why?
|
| Neodymium | 1 | 2020 | 6 | 0.680 |
Why?
|
| Cholecystectomy, Laparoscopic | 1 | 2020 | 44 | 0.670 |
Why?
|
| Lithotripsy | 1 | 2020 | 22 | 0.660 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2020 | 62 | 0.660 |
Why?
|
| Anesthetics, General | 1 | 2019 | 5 | 0.640 |
Why?
|
| Job Syndrome | 1 | 2019 | 17 | 0.630 |
Why?
|
| Rectal Neoplasms | 1 | 2020 | 78 | 0.620 |
Why?
|
| Ergonomics | 3 | 2023 | 20 | 0.610 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 130 | 0.610 |
Why?
|
| Choledochal Cyst | 1 | 2018 | 8 | 0.600 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 121 | 0.590 |
Why?
|
| Gastrointestinal Diseases | 5 | 2022 | 343 | 0.580 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 133 | 0.580 |
Why?
|
| Anesthesia | 1 | 2020 | 206 | 0.560 |
Why?
|
| Child, Preschool | 28 | 2025 | 14221 | 0.550 |
Why?
|
| Biliary Tract | 1 | 2017 | 15 | 0.550 |
Why?
|
| Adolescent | 35 | 2025 | 19548 | 0.550 |
Why?
|
| Pandemics | 6 | 2022 | 1129 | 0.530 |
Why?
|
| Practice Patterns, Physicians' | 3 | 2017 | 740 | 0.520 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 1029 | 0.500 |
Why?
|
| Abdominal Pain | 6 | 2022 | 307 | 0.500 |
Why?
|
| Documentation | 2 | 2016 | 113 | 0.480 |
Why?
|
| Registries | 6 | 2025 | 1454 | 0.480 |
Why?
|
| Digestive System Surgical Procedures | 3 | 2020 | 86 | 0.480 |
Why?
|
| Coronavirus Infections | 4 | 2020 | 367 | 0.460 |
Why?
|
| Pneumonia, Viral | 4 | 2020 | 381 | 0.460 |
Why?
|
| Quality Indicators, Health Care | 2 | 2017 | 221 | 0.440 |
Why?
|
| Calculi | 1 | 2013 | 14 | 0.430 |
Why?
|
| Intestine, Small | 2 | 2011 | 311 | 0.430 |
Why?
|
| Pancreatic Neoplasms | 5 | 2022 | 698 | 0.420 |
Why?
|
| Cecum | 3 | 2022 | 27 | 0.420 |
Why?
|
| Bile Duct Neoplasms | 4 | 2023 | 111 | 0.410 |
Why?
|
| Gallbladder Diseases | 2 | 2011 | 24 | 0.410 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 858 | 0.410 |
Why?
|
| Bile Duct Diseases | 1 | 2012 | 17 | 0.400 |
Why?
|
| Liver Transplantation | 5 | 2025 | 1077 | 0.390 |
Why?
|
| Appointments and Schedules | 3 | 2020 | 49 | 0.380 |
Why?
|
| Male | 42 | 2025 | 62031 | 0.380 |
Why?
|
| Self Expandable Metallic Stents | 2 | 2021 | 7 | 0.360 |
Why?
|
| Cecal Diseases | 1 | 2010 | 6 | 0.330 |
Why?
|
| Appendix | 1 | 2010 | 15 | 0.330 |
Why?
|
| United States | 17 | 2022 | 10990 | 0.330 |
Why?
|
| Betacoronavirus | 4 | 2020 | 294 | 0.330 |
Why?
|
| Female | 39 | 2025 | 67333 | 0.330 |
Why?
|
| Stents | 6 | 2021 | 839 | 0.320 |
Why?
|
| Surveys and Questionnaires | 7 | 2022 | 3716 | 0.310 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2008 | 9 | 0.300 |
Why?
|
| Intestinal Obstruction | 1 | 2010 | 93 | 0.300 |
Why?
|
| Health Care Costs | 2 | 2025 | 376 | 0.290 |
Why?
|
| Consensus | 6 | 2022 | 655 | 0.290 |
Why?
|
| Pain Management | 2 | 2020 | 182 | 0.290 |
Why?
|
| Genetic Predisposition to Disease | 6 | 2022 | 3203 | 0.280 |
Why?
|
| Infant | 13 | 2025 | 12681 | 0.270 |
Why?
|
| Retrospective Studies | 16 | 2025 | 16517 | 0.270 |
Why?
|
| Bone Marrow Neoplasms | 1 | 2007 | 23 | 0.270 |
Why?
|
| Abdominal Neoplasms | 1 | 2007 | 32 | 0.270 |
Why?
|
| Fellowships and Scholarships | 2 | 2024 | 286 | 0.260 |
Why?
|
| Risk Factors | 15 | 2023 | 10375 | 0.260 |
Why?
|
| Trypsin Inhibitor, Kazal Pancreatic | 2 | 2024 | 6 | 0.260 |
Why?
|
| Postoperative Complications | 4 | 2025 | 3078 | 0.250 |
Why?
|
| Cholangiocarcinoma | 3 | 2023 | 110 | 0.250 |
Why?
|
| Rhabdomyosarcoma | 1 | 2008 | 193 | 0.240 |
Why?
|
| Radiography | 3 | 2019 | 805 | 0.240 |
Why?
|
| Databases, Factual | 4 | 2019 | 1193 | 0.240 |
Why?
|
| Autoimmune Diseases | 2 | 2018 | 260 | 0.240 |
Why?
|
| Stomach Neoplasms | 2 | 2020 | 550 | 0.230 |
Why?
|
| Electric Power Supplies | 2 | 2021 | 15 | 0.230 |
Why?
|
| Prospective Studies | 6 | 2022 | 6175 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 6 | 2020 | 1274 | 0.220 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 431 | 0.210 |
Why?
|
| Informed Consent | 3 | 2022 | 336 | 0.210 |
Why?
|
| Hypertriglyceridemia | 1 | 2024 | 107 | 0.210 |
Why?
|
| Adult | 15 | 2022 | 29802 | 0.210 |
Why?
|
| Watchful Waiting | 2 | 2020 | 71 | 0.200 |
Why?
|
| Eating | 3 | 2020 | 376 | 0.200 |
Why?
|
| Duodenoscopes | 1 | 2022 | 3 | 0.200 |
Why?
|
| Elective Surgical Procedures | 2 | 2020 | 161 | 0.200 |
Why?
|
| Catheterization | 2 | 2022 | 227 | 0.200 |
Why?
|
| Constriction, Pathologic | 3 | 2025 | 237 | 0.200 |
Why?
|
| Exocrine Pancreatic Insufficiency | 1 | 2022 | 35 | 0.190 |
Why?
|
| Cohort Studies | 9 | 2023 | 4874 | 0.190 |
Why?
|
| Treatment Outcome | 9 | 2025 | 12380 | 0.190 |
Why?
|
| Triglycerides | 1 | 2024 | 577 | 0.190 |
Why?
|
| Hemangiosarcoma | 1 | 2022 | 41 | 0.190 |
Why?
|
| Neuroblastoma | 1 | 2007 | 530 | 0.190 |
Why?
|
| Sphincterotomy, Endoscopic | 2 | 2019 | 12 | 0.190 |
Why?
|
| Radiation Exposure | 1 | 2022 | 46 | 0.180 |
Why?
|
| Cholangitis | 1 | 2021 | 36 | 0.180 |
Why?
|
| Bone Density | 1 | 2023 | 324 | 0.180 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 2 | 2019 | 11 | 0.180 |
Why?
|
| Gastric Outlet Obstruction | 1 | 2020 | 15 | 0.180 |
Why?
|
| Colorectal Neoplasms | 2 | 2020 | 581 | 0.170 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2020 | 31 | 0.170 |
Why?
|
| Intestinal Polyposis | 1 | 2020 | 17 | 0.170 |
Why?
|
| Chymotrypsin | 2 | 2017 | 16 | 0.170 |
Why?
|
| Smad4 Protein | 1 | 2020 | 57 | 0.170 |
Why?
|
| Trypsin | 2 | 2017 | 93 | 0.170 |
Why?
|
| Umbilical Veins | 1 | 2020 | 71 | 0.170 |
Why?
|
| Colectomy | 1 | 2020 | 74 | 0.170 |
Why?
|
| Sphincter of Oddi Dysfunction | 1 | 2019 | 1 | 0.170 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 41 | 0.170 |
Why?
|
| Magnets | 1 | 2020 | 22 | 0.170 |
Why?
|
| Colonic Pseudo-Obstruction | 1 | 2019 | 3 | 0.170 |
Why?
|
| Sigmoid Diseases | 1 | 2019 | 7 | 0.170 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2019 | 12 | 0.170 |
Why?
|
| Heller Myotomy | 1 | 2019 | 7 | 0.170 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2020 | 73 | 0.170 |
Why?
|
| Adenomatous Polyposis Coli | 1 | 2020 | 42 | 0.160 |
Why?
|
| Clinical Laboratory Services | 1 | 2020 | 19 | 0.160 |
Why?
|
| Acetylcholine Release Inhibitors | 1 | 2019 | 19 | 0.160 |
Why?
|
| Conservative Treatment | 1 | 2019 | 36 | 0.160 |
Why?
|
| Patient Selection | 2 | 2020 | 703 | 0.160 |
Why?
|
| Dilatation | 1 | 2019 | 66 | 0.160 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 167 | 0.160 |
Why?
|
| Proctoscopy | 1 | 2019 | 6 | 0.160 |
Why?
|
| Rectal Diseases | 1 | 2019 | 18 | 0.160 |
Why?
|
| Esophageal Achalasia | 1 | 2019 | 42 | 0.160 |
Why?
|
| Intestinal Volvulus | 1 | 2019 | 38 | 0.160 |
Why?
|
| Decompression, Surgical | 1 | 2019 | 90 | 0.160 |
Why?
|
| Tobacco Smoking | 1 | 2019 | 20 | 0.160 |
Why?
|
| Burkitt Lymphoma | 1 | 2020 | 146 | 0.160 |
Why?
|
| Occupational Exposure | 1 | 2020 | 130 | 0.150 |
Why?
|
| Infection Control | 1 | 2020 | 146 | 0.150 |
Why?
|
| Preservation, Biological | 1 | 2018 | 9 | 0.150 |
Why?
|
| Communicable Disease Control | 1 | 2020 | 138 | 0.150 |
Why?
|
| Algorithms | 3 | 2020 | 1647 | 0.150 |
Why?
|
| Choledochostomy | 1 | 2018 | 5 | 0.150 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 152 | 0.150 |
Why?
|
| Rectum | 1 | 2019 | 102 | 0.150 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2019 | 99 | 0.150 |
Why?
|
| Curriculum | 1 | 2024 | 735 | 0.150 |
Why?
|
| Young Adult | 8 | 2020 | 9174 | 0.150 |
Why?
|
| Analgesics, Opioid | 2 | 2020 | 417 | 0.150 |
Why?
|
| Fluoroscopy | 3 | 2023 | 91 | 0.150 |
Why?
|
| Biological Specimen Banks | 1 | 2018 | 51 | 0.150 |
Why?
|
| Quality of Life | 3 | 2024 | 1954 | 0.150 |
Why?
|
| Botulinum Toxins | 1 | 2019 | 121 | 0.150 |
Why?
|
| Cation Transport Proteins | 2 | 2011 | 94 | 0.150 |
Why?
|
| Time Factors | 2 | 2019 | 6334 | 0.150 |
Why?
|
| Bile Ducts, Extrahepatic | 1 | 2018 | 14 | 0.150 |
Why?
|
| Diagnosis, Differential | 3 | 2018 | 1909 | 0.140 |
Why?
|
| Infant, Newborn | 4 | 2020 | 8308 | 0.140 |
Why?
|
| Radiation Injuries | 1 | 2019 | 144 | 0.140 |
Why?
|
| Specimen Handling | 1 | 2018 | 142 | 0.140 |
Why?
|
| North America | 4 | 2020 | 245 | 0.140 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 3457 | 0.140 |
Why?
|
| Hemangioma | 1 | 2018 | 94 | 0.140 |
Why?
|
| Age Factors | 3 | 2020 | 2835 | 0.140 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 193 | 0.140 |
Why?
|
| Jaundice, Obstructive | 1 | 2017 | 5 | 0.140 |
Why?
|
| Overweight | 2 | 2018 | 368 | 0.140 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2018 | 99 | 0.140 |
Why?
|
| Biliary Tract Diseases | 1 | 2017 | 37 | 0.140 |
Why?
|
| Education, Medical, Graduate | 2 | 2024 | 525 | 0.130 |
Why?
|
| Capsule Endoscopy | 1 | 2017 | 20 | 0.130 |
Why?
|
| Research Design | 2 | 2018 | 709 | 0.130 |
Why?
|
| Hospital Units | 1 | 2016 | 17 | 0.130 |
Why?
|
| Lipids | 1 | 2020 | 524 | 0.130 |
Why?
|
| Certification | 1 | 2017 | 66 | 0.130 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 347 | 0.130 |
Why?
|
| Education, Medical, Continuing | 1 | 2017 | 143 | 0.130 |
Why?
|
| Biomedical Research | 3 | 2018 | 526 | 0.130 |
Why?
|
| Biopsy | 2 | 2024 | 1257 | 0.120 |
Why?
|
| Lipase | 1 | 2016 | 94 | 0.120 |
Why?
|
| Societies, Medical | 4 | 2020 | 709 | 0.120 |
Why?
|
| Liver Failure, Acute | 1 | 2016 | 92 | 0.120 |
Why?
|
| Program Development | 1 | 2016 | 182 | 0.120 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2015 | 53 | 0.120 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 771 | 0.120 |
Why?
|
| Barrett Esophagus | 1 | 2019 | 348 | 0.120 |
Why?
|
| Digestive System | 1 | 2015 | 63 | 0.120 |
Why?
|
| Esophageal Neoplasms | 1 | 2019 | 376 | 0.120 |
Why?
|
| Hospital Costs | 1 | 2016 | 180 | 0.110 |
Why?
|
| Length of Stay | 1 | 2020 | 1325 | 0.110 |
Why?
|
| Cathartics | 1 | 2014 | 28 | 0.110 |
Why?
|
| Internet | 1 | 2017 | 378 | 0.110 |
Why?
|
| Mutation | 5 | 2024 | 5965 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2017 | 391 | 0.110 |
Why?
|
| Intestinal Polyps | 1 | 2014 | 29 | 0.110 |
Why?
|
| Mass Screening | 4 | 2022 | 785 | 0.110 |
Why?
|
| Ileal Diseases | 1 | 2014 | 21 | 0.110 |
Why?
|
| Faculty, Medical | 1 | 2017 | 262 | 0.110 |
Why?
|
| History, 20th Century | 1 | 2016 | 390 | 0.110 |
Why?
|
| Hospitalization | 3 | 2020 | 1800 | 0.110 |
Why?
|
| Cholelithiasis | 1 | 2013 | 18 | 0.110 |
Why?
|
| Lasers, Solid-State | 1 | 2013 | 18 | 0.110 |
Why?
|
| Early Detection of Cancer | 3 | 2022 | 367 | 0.100 |
Why?
|
| Hepatic Artery | 1 | 2013 | 51 | 0.100 |
Why?
|
| Drainage | 3 | 2021 | 260 | 0.100 |
Why?
|
| Gastrostomy | 1 | 2014 | 87 | 0.100 |
Why?
|
| Gallstones | 2 | 2011 | 18 | 0.100 |
Why?
|
| Bile Ducts | 2 | 2013 | 53 | 0.100 |
Why?
|
| Intestine, Large | 1 | 2012 | 14 | 0.100 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2012 | 27 | 0.100 |
Why?
|
| Adenomatous Polyps | 1 | 2012 | 13 | 0.100 |
Why?
|
| Mucous Membrane | 1 | 2012 | 90 | 0.100 |
Why?
|
| Secondary Prevention | 1 | 2013 | 215 | 0.100 |
Why?
|
| Preoperative Care | 1 | 2014 | 358 | 0.100 |
Why?
|
| Disease Progression | 4 | 2019 | 2103 | 0.100 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 306 | 0.090 |
Why?
|
| Diabetes Mellitus | 3 | 2018 | 885 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 2106 | 0.090 |
Why?
|
| Colonic Polyps | 1 | 2012 | 78 | 0.090 |
Why?
|
| Helicobacter pylori | 1 | 2020 | 1325 | 0.090 |
Why?
|
| Helicobacter Infections | 1 | 2020 | 1268 | 0.090 |
Why?
|
| Neoplasm Staging | 2 | 2019 | 1291 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2013 | 219 | 0.090 |
Why?
|
| Follow-Up Studies | 5 | 2022 | 5204 | 0.080 |
Why?
|
| Prevalence | 4 | 2019 | 2484 | 0.080 |
Why?
|
| Personal Protective Equipment | 2 | 2020 | 55 | 0.080 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2016 | 794 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 1282 | 0.080 |
Why?
|
| Obesity | 2 | 2018 | 2276 | 0.080 |
Why?
|
| Hyperglycemia | 1 | 2010 | 228 | 0.080 |
Why?
|
| Severity of Illness Index | 3 | 2024 | 2933 | 0.080 |
Why?
|
| Multicenter Studies as Topic | 2 | 2019 | 274 | 0.070 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2011 | 139 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2018 | 3622 | 0.070 |
Why?
|
| Delphi Technique | 2 | 2022 | 214 | 0.070 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2008 | 145 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 1334 | 0.070 |
Why?
|
| Cost of Illness | 2 | 2022 | 255 | 0.070 |
Why?
|
| Combined Modality Therapy | 2 | 2013 | 1251 | 0.070 |
Why?
|
| Crohn Disease | 2 | 2011 | 282 | 0.070 |
Why?
|
| Adenoma | 1 | 2009 | 133 | 0.070 |
Why?
|
| Canada | 2 | 2019 | 291 | 0.070 |
Why?
|
| Brain | 1 | 2019 | 3034 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2008 | 369 | 0.070 |
Why?
|
| Iron | 2 | 2006 | 281 | 0.070 |
Why?
|
| Palliative Care | 2 | 2021 | 440 | 0.070 |
Why?
|
| Malabsorption Syndromes | 1 | 2006 | 36 | 0.070 |
Why?
|
| Salmonella enterica | 1 | 2006 | 9 | 0.060 |
Why?
|
| Intestinal Absorption | 1 | 2006 | 190 | 0.060 |
Why?
|
| Intestinal Mucosa | 1 | 2011 | 784 | 0.060 |
Why?
|
| Cholecystectomy | 2 | 2019 | 61 | 0.060 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2016 | 44 | 0.060 |
Why?
|
| International Cooperation | 2 | 2017 | 160 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2020 | 1204 | 0.060 |
Why?
|
| Disease Management | 2 | 2019 | 529 | 0.060 |
Why?
|
| Transglutaminases | 1 | 2024 | 24 | 0.060 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2024 | 17 | 0.060 |
Why?
|
| Demography | 2 | 2019 | 240 | 0.050 |
Why?
|
| Age of Onset | 2 | 2017 | 608 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2024 | 177 | 0.050 |
Why?
|
| Immunoglobulin A | 1 | 2024 | 207 | 0.050 |
Why?
|
| Image-Guided Biopsy | 1 | 2023 | 38 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2013 | 943 | 0.050 |
Why?
|
| Posture | 1 | 2023 | 149 | 0.050 |
Why?
|
| Middle Aged | 5 | 2020 | 27031 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2022 | 58 | 0.050 |
Why?
|
| Splenic Vein | 1 | 2021 | 11 | 0.050 |
Why?
|
| Ileum | 1 | 2022 | 134 | 0.050 |
Why?
|
| Pancreaticoduodenectomy | 1 | 2022 | 93 | 0.050 |
Why?
|
| Pancreatectomy | 1 | 2022 | 139 | 0.050 |
Why?
|
| Autoantibodies | 1 | 2024 | 434 | 0.040 |
Why?
|
| Animals | 4 | 2019 | 34533 | 0.040 |
Why?
|
| Ventilation | 1 | 2020 | 5 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 1341 | 0.040 |
Why?
|
| Emergency Service, Hospital | 2 | 2020 | 1080 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2020 | 110 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2020 | 101 | 0.040 |
Why?
|
| Neostigmine | 1 | 2019 | 6 | 0.040 |
Why?
|
| Emergencies | 1 | 2021 | 173 | 0.040 |
Why?
|
| Myotomy | 1 | 2019 | 19 | 0.040 |
Why?
|
| Colostomy | 1 | 2019 | 26 | 0.040 |
Why?
|
| Manometry | 1 | 2019 | 60 | 0.040 |
Why?
|
| Israel | 1 | 2019 | 46 | 0.040 |
Why?
|
| Pancreatic Ducts | 1 | 2019 | 20 | 0.040 |
Why?
|
| Mirizzi Syndrome | 1 | 2019 | 1 | 0.040 |
Why?
|
| Triage | 1 | 2020 | 140 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2019 | 194 | 0.040 |
Why?
|
| Internationality | 1 | 2020 | 134 | 0.040 |
Why?
|
| Europe | 1 | 2020 | 362 | 0.040 |
Why?
|
| Costs and Cost Analysis | 1 | 2020 | 163 | 0.040 |
Why?
|
| Australia | 1 | 2019 | 146 | 0.040 |
Why?
|
| International Agencies | 1 | 2018 | 30 | 0.040 |
Why?
|
| Ultrasonography, Interventional | 1 | 2020 | 191 | 0.040 |
Why?
|
| Incidence | 2 | 2018 | 3170 | 0.040 |
Why?
|
| Hemangioendothelioma | 1 | 2018 | 24 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2019 | 158 | 0.040 |
Why?
|
| Germ-Line Mutation | 1 | 2020 | 343 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2018 | 89 | 0.040 |
Why?
|
| Pain Measurement | 1 | 2019 | 345 | 0.040 |
Why?
|
| Microscopy, Confocal | 1 | 2019 | 353 | 0.040 |
Why?
|
| Myocardial Contraction | 2 | 1998 | 265 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2019 | 784 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2018 | 194 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 178 | 0.030 |
Why?
|
| Pancreatic Function Tests | 1 | 2017 | 3 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2020 | 325 | 0.030 |
Why?
|
| Contraindications, Procedure | 1 | 2017 | 4 | 0.030 |
Why?
|
| Vascular Malformations | 1 | 2018 | 92 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2018 | 224 | 0.030 |
Why?
|
| Facility Design and Construction | 1 | 2016 | 4 | 0.030 |
Why?
|
| SEER Program | 1 | 2018 | 205 | 0.030 |
Why?
|
| Models, Educational | 1 | 2017 | 74 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2900 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 1266 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2017 | 78 | 0.030 |
Why?
|
| Efficiency, Organizational | 1 | 2016 | 55 | 0.030 |
Why?
|
| Aortic Valve Insufficiency | 1 | 1998 | 149 | 0.030 |
Why?
|
| Liver | 2 | 2014 | 1758 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 867 | 0.030 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2016 | 81 | 0.030 |
Why?
|
| Survival Analysis | 1 | 2019 | 1517 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 1380 | 0.030 |
Why?
|
| Sex Factors | 1 | 2019 | 1293 | 0.030 |
Why?
|
| Heart Aneurysm | 1 | 1995 | 37 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1998 | 589 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 1073 | 0.030 |
Why?
|
| Global Health | 1 | 2019 | 574 | 0.030 |
Why?
|
| Laxatives | 1 | 2014 | 9 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 1129 | 0.030 |
Why?
|
| Database Management Systems | 1 | 2014 | 31 | 0.030 |
Why?
|
| Meckel Diverticulum | 1 | 2014 | 10 | 0.030 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 443 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 782 | 0.030 |
Why?
|
| Lithotripsy, Laser | 1 | 2013 | 13 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 477 | 0.030 |
Why?
|
| Genetic Testing | 1 | 2020 | 1021 | 0.030 |
Why?
|
| Hemoperitoneum | 1 | 2013 | 9 | 0.030 |
Why?
|
| Diet, Fat-Restricted | 1 | 2013 | 40 | 0.030 |
Why?
|
| alpha 1-Antitrypsin Deficiency | 1 | 2013 | 37 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 1994 | 185 | 0.030 |
Why?
|
| Bicycling | 1 | 2013 | 35 | 0.030 |
Why?
|
| Lacerations | 1 | 2013 | 33 | 0.030 |
Why?
|
| Celecoxib | 1 | 2012 | 30 | 0.030 |
Why?
|
| Radiography, Interventional | 1 | 2013 | 82 | 0.020 |
Why?
|
| Survival Rate | 1 | 2018 | 2070 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 813 | 0.020 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2012 | 53 | 0.020 |
Why?
|
| Hematoma | 1 | 2013 | 92 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2013 | 129 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1995 | 375 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2018 | 1582 | 0.020 |
Why?
|
| Pleural Effusion | 1 | 2013 | 107 | 0.020 |
Why?
|
| Data Collection | 1 | 2014 | 379 | 0.020 |
Why?
|
| Abdominal Injuries | 1 | 2013 | 115 | 0.020 |
Why?
|
| Anemia, Hemolytic | 1 | 2011 | 30 | 0.020 |
Why?
|
| Hypotension | 1 | 2013 | 186 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2013 | 213 | 0.020 |
Why?
|
| Blood Transfusion | 1 | 2013 | 314 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2016 | 1029 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2012 | 270 | 0.020 |
Why?
|
| Duodenum | 1 | 2011 | 101 | 0.020 |
Why?
|
| Hemorrhage | 1 | 2014 | 473 | 0.020 |
Why?
|
| Phenotype | 1 | 2020 | 4323 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2012 | 313 | 0.020 |
Why?
|
| Aged | 2 | 2020 | 19962 | 0.020 |
Why?
|
| Cerebral Palsy | 1 | 2010 | 80 | 0.020 |
Why?
|
| DNA | 1 | 2014 | 1621 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2011 | 1110 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 434 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 1300 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 1725 | 0.020 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 1998 | 99 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 2 | 1998 | 258 | 0.020 |
Why?
|
| Hepcidins | 1 | 2006 | 26 | 0.020 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2006 | 38 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 2818 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2011 | 3341 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 2010 | 1057 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 6645 | 0.010 |
Why?
|
| Macrophages | 1 | 2006 | 642 | 0.010 |
Why?
|
| Myocardium | 2 | 1998 | 1029 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 4742 | 0.010 |
Why?
|
| Cell Line | 1 | 2006 | 2734 | 0.010 |
Why?
|
| Cytokines | 1 | 2006 | 1306 | 0.010 |
Why?
|
| Inflammation | 1 | 2006 | 1462 | 0.010 |
Why?
|
| Systole | 1 | 1998 | 201 | 0.010 |
Why?
|
| Diastole | 1 | 1998 | 178 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 1998 | 170 | 0.010 |
Why?
|
| Biomarkers | 1 | 2006 | 3153 | 0.010 |
Why?
|
| Mathematics | 1 | 1995 | 97 | 0.010 |
Why?
|
| Sheep | 1 | 1995 | 220 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 1 | 1998 | 303 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 1998 | 520 | 0.010 |
Why?
|
| Elasticity | 1 | 1994 | 94 | 0.010 |
Why?
|
| Dogs | 1 | 1994 | 773 | 0.010 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 1998 | 442 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1998 | 784 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1995 | 501 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1998 | 2068 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1994 | 845 | 0.010 |
Why?
|
| Heart | 1 | 1994 | 736 | 0.000 |
Why?
|
| Mice | 1 | 2006 | 17881 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1995 | 4467 | 0.000 |
Why?
|